PLx Pharma Inc.

PLXP · NASDAQ
Analyze with AI
9/30/2022
6/30/2022
3/31/2022
12/31/2021
Assets
Cash & Equivalents$25,834$35,730$52,499$69,392
Short-Term Investments$0$0$0$0
Receivables$139$490$698$634
Inventory$3,178$3,883$3,839$2,458
Other Curr. Assets$1,070$1,376$712$992
Total Curr. Assets$30,221$41,479$57,748$73,476
Property Plant & Equip (Net)$942$1,000$1,032$1,088
Goodwill$2,061$2,061$2,061$2,061
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$17$17
Total NC Assets$3,003$3,061$3,110$3,166
Other Assets$0$0$0$0
Total Assets$33,224$44,540$60,858$76,642
Liabilities
Payables$5,069$8,212$12,716$10,600
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$1,243$856$514$1,279
Total Curr. Liab.$6,312$9,068$13,230$11,879
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$711$2,967$5,645$13,083
Total NC Liab.$711$2,967$5,645$13,083
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$7,023$12,035$18,875$24,962
Equity
Pref Stock$16,014$16,014$16,014$16,014
Common Stock$29$28$28$28
Retained Earnings-$179,414-$170,917-$159,059-$148,274
AOCI$0$0$0$0
Other Equity$189,572$187,380$185,000$183,912
Total Equity$26,201$32,505$41,983$51,680
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$33,224$44,540$60,858$76,642
Net Debt-$25,834-$35,730-$52,499-$69,392